Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Have gravitational waves provided the first hint of primordial black holes born during the Big Bang? - 2Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- 3Doctor's orders? ‘Belly laugh at least two to five days a week'
- 4Find the Keys to Fruitful Venture The board: Conveying Results on Time
- 5RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object.
- Figure out how to Guarantee Your Dental Embeds Endure forever
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- Step by step instructions to Explore the Close to home Consequence of Cellular breakdown in the lungs
- AstraZeneca to invest $2 billion as part of US manufacturing push
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- Find the Historical backdrop of the Modern Unrest: Changing Society and Innovation
- 7 Extraordinary Efficiency Applications for Experts
